A retrospective study of renal deterioration after high doses (80 g I) o f int ravenous contrast medium was done o f 286 adult patients. The incidence, duration , and severit y of renal deterioration were compared with those reported in a series of 377 similar patients after low dose contrast infusion (43 g I). No statistically signif icant difference between these groups was seen in nondiabetics with a preinfusion serum creat inine below 4.5 mg / dl. A prospective study of fractional excretions in 35 patients receiving high dose infusion demonstrated no additional subtle renal damage in 34 patients. One patient developed a transient rise in serum creatinine that was identical t o t he course of renal deterioration after 43 g of iodine. It is concluded that the severity and duration of renal deterioration was not affected by the dose of contrast material (43-80 g iodine).
The dose of intravenous c ontrast substance recommended for computed tomograpy (CT) has gradually risen from 21 9 iodine in 1975 to 56 9 in 1978 [1 , 2] . During the past few years we found that an 80 9 iodine dose of contrast medium appreciably improved the CT display of c lini cally useful information [3 -7] . Although iodine doses of that degree are used in angiographi c procedures [8] , their use in intravenous infusion for CT of the head is not yet wid espread .
Our study was undertaken to evaluate the incidence and severity of renal dysfunction after rapid intravenous administration of an 80 9 iodine dose of contrast medium . Th e study was in two parts: (1) a prospective study of 3 5 pati ents who w ere c losely monitored and (2) a retrospective study of 286 pati ents by chart revi ew .
Materials and Methods
Th e prospective study of renal injury was perform ed on 3 5 adult , nondiabeti c patien ts wh o underwent cranial CT during rapid intravenous infu sion of diatrozoate meg lumine containing 8 0 g iodine. Renal fun cti on was normal in 28 pati ents (serum creat inine less than 1 .2 mg / dl) and seven had impaired renal func ti on (serum c reatinin e 1 .2-4. 5 mg / d l).
On the day before CT and 1 and 3 days after contrast medium infusion, th e following valu es were determined : hematocrit , hemoglobin , serum c reatinine, sodium, potassium , c hl orid e, carbon dioxi de, calc ium , alkaline ph osph atase, serum protein fractions, c holesterol, trigl yce rid es, bilirubin , SGOT, SGPT, and lacti c dehydrogenase. In add iti on , 24 hr urine spec im ens were coll ected on all pati ents to determin e urine volume, creatinin e, protein , potassium , calci um , uric acid, and ph osphate.
Th e retrospective stud y of 286 adult pati ents wh o had c rani al CT scans du ring infu sion of an 8 0 g iodine d ose of co ntrast medium was done by c hart revi ew. Serum c reatinin e and bl ood urea valu es obtain ed withi n 7 d ays before and after co ntrast infu sion as well as evidence indicating presence or absence of preexisting renal d isease and / or diabetes mellitu s were avail able in all patients. Of th e 286 pati ents, 11 had diabetes ; 275 did not.
HA YMAN ET AL. . Pr einfusio n serum c rea tini ne levels for group I = < 1.5 mg / dl; g ro up II = 1.5-4 .5 mg / dl : group III = > 4 .5 mg / dl.
Th e pati ents were divided into three categori es: group /-preinfu sion serum c reatinin e o f less th an 1 .5 mg / dl (thi s group included normal subjects as well as those with unrecognized renal disease with onl y mildly reduc ed renal fun ction) ; group J/-preinfusion serum c rea tinine of 1.5-4.5 mg / dl; and group 1//-severe renal impairment manifested by serum c reatinin e levels in excess of 4.5 mg / d l before infusion .
Contra st-associated renal dysfunction was diagnosed wh en the previously stable c rea tinin e in c reased at least 1 .0 mg / dl , with or without oliguria, and no nephrotoxic factor other than meglumine diatrozoate was present. Only three pati ents with renal dysfunction were excluded because of multiplicity of nephroto xic factors (nephroto xic drugs, sepsis, or rapid ly fai ling rena l function) .
About 570 ml o f Reno-M-DIP (Squibb) was infused intravenously fo r co ntrast-enhanced CT brain scans. Th e first 270 ml (37.7 g iod in e) was g iven by pressure infusion in 90-120 sec. Abou t 30 ml was retained in the first bottle as a precaution against air embolization . A second bottle of 3 00 ml (42 .3 g iod in e) was administered by rapid d rip over th e next 5-7 min . Th e meal before examination was omitted and hydrati on maintained with surgica l fluids .
Results

Prospec tive Study
Renal tubular function was unchanged in 34 of the 35 patients who were monitored before and after contrast medium infusion of 80 g iodine. Hematocrit, hemoglobin , cholesterol, triglycerides, bilirubin, and enzymes were unchang ed in all patients. No uricosuric effect was noted . In the last patient ac ute ren al deterioration developed . He was oliguric (urine volume averaging 40 ml/ hr) for 48 hr after contrast infusion . His serum creatinine measurements before as well as 1, 2, 3, and 7 days after infusion were 3.3, 5 .1 , 6 .3 , 9 .3 , and 3.8 mg / dl, respectively . Dialysis was not performed. Th e tubular damage recorded by the rise in serum c reatinine was reflected in the more sensitive measu rements of fractional excretions.
It should be noted th at this patient had been exposed to other nephrotoxic factors . He had been treated for bil ateral pneumonia and sepsis with gentamicin (100 mg followed by 40 mg every 8 hr) for 1 week immediately before contrast infusion . He was also being treated for severe congestive hea rt failure . He had diffuse atherosclerotic vascular disease that was manifested by previous cerebral infarction and renal insufficiency (baseline of 3 .3 mg / dl). It is likely that the contrast medium was at least partly responsible for the ren al deterioration, but the sepsis, nephrotoxic drugs, congestive heart failure, and preexisting renal insufficiency cannot arbitrarily be exonerated.
Retrospective Study
Both pre-and postinfusion serum creatinine values were recorded on 286 patients. Results for the 275 nondiabetic patients are presented in table 1 and for the 11 diabetic patients in table 2. Eight of the 286 patients showed postinfusion renal deterioration (six nondiabetics and two diabetics). Six of these showed return of serum creatinine values to baseline levels within 14 days after infusion. Two nondi abetics with preexisting severe renal disease died of ca uses unrelated to the renal disease or the infusion of contrast medium . One of the eight who had been severely dehydrated experienced transient oliguria.
Discussion
It is widely accepted, without documentation, that the inc idence of renal deterioration after infusion of modern ·contrast media is dose related. However, c linical studies do not support this position insofar as arterial injections are concerned. Doses as high as 103 g iodine have been used in arteriography [9 , 10] , but the effect of such high doses administered intravenously has not previously been evaluated.
Our retrospective study was patterned after that of VanZee et al. [11] who reported the incidence of renal damage after drip infusion of a " standard dose " of meglumin e diatrizoate (43 g iodine) in hospitalized patients. The same cri teria were used for patient selection , definition of renal failure , and classification of patients. In addition, meglumin e diatrizoate (Reno-M -DIP) was used in both studies. Only the total amount of contrast medium and the rate of ad mini stration differed .
The incidence of renal deterioration in the week after a high dose (80 9 iodine) was compared with that reported after a low dose (43 9 iodine). In three groups of nondiabetics (table 1) there was no difference in the rate of renal deterioration at even the 10% level, based on the one-tailed Fisher exact possibility te st. Upper limits of 95 % confidence intervals for the rate of renal deterioration at the two dose levels of iodine were 3 .9 % and 3 .1 %, respectively, in group I and 10,5% and 13.5%, respectively , in group II. In group III, the numbers were too small to justify definitive conclusions. Recent reports on small numbers of patients indicate an increased risk of renal deterioration in group III patients and diabetics in groups II and III (table 2) [11 -13] . This information has compelled practitioners to limit the number of these patients to whom iodine contrast is administered and has therefore limited the reservoir of clinical material available for evaluation of renal deterioration. Fortunately most patients referred for cranial CT do not fit into these groups .
In our prospective study, the serum creatin ine value was sufficient to detect renal deterioration . Additional subtle changes in fractional excretion electrolytes or creatinine were not seen in the absence of serum creatinine changes. The possibility of such subtle damage suggested by Older et al. [14] was not substantiated .
In summary , our studies offer no evidence that larger doses of intravenously administered contrast medium increase the risk or severity of permanent renal injury. In the eight patients in whom renal deterioration occurred after an 80 g dose , the clinical course and duration were identical to that reported after 43 g iodine infusion. In nondiabetic patients with serum creatinine of less than 4.5 mg / dl (271 patients in groups I and II) the rate of renal injury was unaffected by the contrast medium dose in the 43-80 g range. In patients with severe renal impairment and diabetes , limited clinical data indicate that caution should be used when administering any dose of contrast medium.
